Thomas Kwiatkowski

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Hypertension and Its Treatment in the NINDS rt-PA Stroke Trial”.

Hypertension and Its Treatment in the NINDS rt-PA Stroke Trial

Stroke(1998)10.1161/01.str.29.8.1504

N/A

0.813DataRank · unranked

225 citations

Mei Lu, Rashmi Kothari, Susan C. Fagan, Michael Frankel, James C. Grotta +7 more

Research Fundamentals: III. Elements of a Research Protocol for Clinical Trials

Academic Emergency Medicine(1998)10.1111/j.1553-2712.1998.tb02698.x

N/A

0.385DataRank · unranked

12 citations

Thomas Kwiatkowski, Robert Silverman

The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17

BMC Medical Research Methodology(2023)10.1186/s12874-023-02074-5

N/A

0DataRank · unranked

1 citations

Joseph P. Broderick, James C. Grotta, Thomas Kwiatkowski, Steven R. Levine, Michael Frankel +3 more